Deka Bank Deutsche Girozentrale Embecta Corp. Transaction History

Deka Bank Deutsche Girozentrale

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2023	SELL	$23.07 - $32.77 $28,952 - $41,126	-1,255 Reduced 81.65%	282 $8,000
Q4 2022 Feb 01, 2023	SELL	$25.29 - $35.48 $2.52 Million - $3.54 Million	-99,824 Reduced 98.48%	1,537 $39,000
Q3 2022 Nov 02, 2022	SELL	$24.0 - $33.42 $2.09 Million - $2.92 Million	-87,262 Reduced 46.26%	101,361 $2.94 Million
Q2 2022 Aug 03, 2022	BUY	$24.78 - $33.36 $4.67 Million - $6.29 Million	188,623 New	188,623 $4.88 Million

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.17B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.